𝔖 Bobbio Scriptorium
✦   LIBER   ✦

649: ZIRA: A new prognostic biomarker of estrogen receptor-positive (ER+) breast cancers

✍ Scribed by Vendrell, J.; Nguyen, N.T.; Gyorffy, B.; Léon, S.; Grisard, E.; Bachelot, T.; Treilleux, I.; Cohen, P.A.

Book ID
125799470
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
64 KB
Volume
50
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen receptors (ER) in human breast
Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents
✍ Marianne Gotteland; Evelyne May; Françoise May-Levin; Geneviève Contesso; Jean-C 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 843 KB

Background. The response to endocrine therapy is not entirely predictable from the estrogen receptor (ER) and progesterone receptor (PgR) status of primary breast tumors. The authors previously proposed a new prognostic factor, ER.R, which was based on both ER protein and mRNA levels. A previous ana

Estrogen-induced interaction between KLF
Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells
✍ Peng Guo; Xue-Yuan Dong; Ke-Wen Zhao; Xiaodong Sun; Qunna Li; Jin-Tang Dong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 368 KB

## Abstract Kruppel‐like factor 5 (KLF5) is implicated in human breast cancer by frequent genomic deletion and expressional deregulation, but the molecular mechanisms by which KLF5 affects breast tumorigenesis are still unknown. This study was conducted to examine whether and how KLF5 affects the f